Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction on Monday, August 17th. The stock was sold at an average price of $390.67, for a total transaction of $30,081.59. Following the transaction, the executive vice president directly owned 1,189 shares in the company, valued at $464,506.63. This represents a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $394.26, for a total transaction of $30,358.02.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $351.00, for a total transaction of $9,828.00.
• On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $360.21, for a total transaction of $10,085.88.
• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $344.00, for a total transaction of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $414.13, for a total transaction of $10,353.25.
• On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $424.14, for a total transaction of $9,755.22.
• On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $420.12, for a total transaction of $9,662.76.
• On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $439.80, for a total value of $7,916.40.

Intuitive Surgical Stock Down 5.8%

ISRG stock opened at $374.48 on Friday. The firm has a market cap of $132.30 billion, a PE ratio of 42.90, a P/E/G ratio of 2.88 and a beta of 1.46. The business has a 50 day moving average of $389.12 and a 200-day moving average of $437.10. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period last year, the company posted $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 18.4% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Main Street Group LTD bought a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. Compass Financial Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at approximately $30,000. Laurel Wealth Advisors LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $31,000. Vermillion Wealth Management Inc. boosted its holdings in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 25 shares during the period. Finally, Turning Point Benefit Group Inc. boosted its holdings in Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on ISRG shares. Wells Fargo & Company reiterated an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. BTIG Research decreased their price objective on shares of Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating for the company in a report on Friday, July 17th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Royal Bank Of Canada dropped their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, July 13th. Finally, The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $508.68.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical’s robotic-assisted surgery platform continues to attract investor interest, supported by the long-term shift toward minimally invasive procedures and recurring revenue from instruments, accessories and services. Intuitive Surgical robotic surgery platform article
• Positive Sentiment: The company is expanding its manufacturing footprint in Asia-Pacific with a new Penang facility. The plant should increase production capacity and position ISRG to serve rising regional demand for robotic surgery systems. Intuitive Surgical expands manufacturing in Asia-Pacific
• Positive Sentiment: Recent quarterly results showed revenue of $2.89 billion, up 18.4% year over year, while adjusted EPS of $2.80 exceeded the $2.48 consensus estimate. Procedures increased about 16%, and 468 da Vinci systems were placed, demonstrating continued demand. Analysts retain a broadly favorable view, with a consensus “Moderate Buy” rating and target prices materially above recent trading levels.
• Neutral Sentiment: Institutional activity was mixed in the latest quarter: 1,070 investors added ISRG shares while 1,306 reduced positions. Large additions by Invesco, JPMorgan and Arrowstreet were offset by notable reductions from T. Rowe Price, FMR and Winslow Capital, suggesting divided sentiment rather than a clear institutional trend.
• Negative Sentiment: Investors remain concerned that Intuitive Surgical maintained its 2026 da Vinci procedure-growth forecast at approximately 13.5%–15.5%, with results expected near the midpoint, despite the strong quarter. Management also expects tariffs to reduce 2026 non-GAAP gross margin by about 1% of revenue, with additional risk if tariffs rise. These factors have contributed to post-earnings valuation pressure. Intuitive Surgical cautious outlook article
• Negative Sentiment: Insider-trading data shows repeated open-market sales and no purchases over the past six months. EVP Mark Brosius’s recent sales totaled roughly $30,000 each and were made under a pre-arranged Rule 10b5-1 plan, limiting their significance individually, but the broader pattern may reinforce investor caution. Intuitive Surgical insider selling article

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.